SEC Form 4 · accession 0001387131-16-005871
Ohr Pharmaceutical Inc · OHRP
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Samuel Backenroth
Officer — Chief Financial Officer
Period of report
Jun 20, 2016
Accepted (ET)
Jun 21, 2016 · 12:41 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001173281
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock, par value $0.0001 per share | Jun 20, 2016 | P | 10 | $2.89 | A | 138,709 | D | |
| Common Stock, par value $0.0001 per share | Jun 20, 2016 | P | 8 | $2.88 | A | 138,717 | D | |
| Common Stock, par value $0.0001 per share | Jun 20, 2016 | P | 450 | $2.87 | A | 139,167 | D | |
| Common Stock, par value $0.0001 per share | Jun 20, 2016 | P | 1,800 | $2.84 | A | 140,967 | D | |
| Common Stock, par value $0.0001 per share | Jun 20, 2016 | P | 200 | $2.71 | A | 141,167 | D |
Table II — derivative securities
No Table II lines on this filing.